How should we obtain a detailed description of the chest pain/anginal symptoms in a male patient in his 90s with chronic angina, extensive coronary artery disease (multiple stents, recent percutaneous coronary intervention to the circumflex, four‑vessel coronary artery bypass graft), chronic kidney disease, hyperlipidemia, and hypertension who is currently on high‑dose ranolazine?

Obtaining a Detailed Description of Chest Pain in a Patient with Extensive CAD and Chronic Angina

Use a systematic, structured approach to characterize this patient's chest pain by documenting the specific quality, location, radiation pattern, duration, precipitating factors, relieving factors, and associated symptoms—this framework distinguishes stable chronic angina from unstable angina or acute coronary syndrome and guides immediate management decisions.

Essential Characteristics to Document

Quality and Location of Discomfort

• Ask specifically about "discomfort" rather than only "pain"—many patients with myocardial ischemia do not experience classic "pain" but rather pressure, tightness, heaviness, squeezing, constricting, burning, or a strangling sensation in the substernal area 1.

• Document the exact location: substernal chest is typical, but radiation to the epigastrium, lower jaw, teeth, between shoulder blades, or either arm (particularly the left) is characteristic of angina 1, 2.

• Pain lasting only seconds is unlikely to be angina; conversely, discomfort persisting beyond 10 minutes—especially if unrelieved by rest or nitroglycerin—raises concern for unstable angina or acute coronary syndrome 1.

Duration and Temporal Pattern

• Brief episodes lasting 2–10 minutes are typical of stable angina, with most episodes resolving in just a few minutes once the precipitating factor stops 1, 2.

• Prolonged rest pain exceeding 20 minutes that does not resolve with rest or sublingual nitroglycerin defines high-risk unstable angina and mandates immediate emergency department transfer 1, 3.

• Document whether symptoms occur at a predictable level of exertion (stable angina) or have an accelerating tempo with increasing frequency, severity, or duration over the preceding 48 hours (unstable angina) 1.

Precipitating and Relieving Factors

• Exertional triggers are the hallmark of stable angina: ask specifically about walking uphill, climbing stairs, walking against wind or cold weather, emotional stress, heavy meals, or symptoms upon waking in the morning 1, 2.

• Document whether symptoms rapidly subside within minutes when exertion stops—this is a defining feature of stable angina 1, 2.

• Response to sublingual nitroglycerin: relief within minutes supports angina, but lack of response does not exclude it, and relief is not specific for myocardial ischemia 1.

• In this patient with 19 prior stents, consider "stretch pain" from stent-related arterial wall stretching, which can mimic angina but is non-ischemic and may persist intermittently for weeks after stent placement 4, 5.

Associated Symptoms

• Shortness of breath may accompany angina or be the sole manifestation of myocardial ischemia—do not dismiss dyspnea as purely pulmonary in a patient with extensive coronary disease 1, 2.

• Less-specific symptoms include fatigue, faintness, nausea, burning, restlessness, or a sense of impending doom—these may be the only clues in atypical presentations, particularly in elderly patients or those with diabetes 1, 2.

• Syncope, presyncope, or hemodynamic instability accompanying chest pain are high-risk features requiring immediate emergency evaluation 1.

Classification Framework

Typical Angina (All Three Criteria Present)

• Substernal chest discomfort of characteristic quality and duration 1, 2.
• Provoked by exertion or emotional stress 1, 2.
• Relieved by rest and/or nitrates within minutes 1, 2.

Atypical Angina (Two of Three Criteria)

• May include pain starting at rest with slow intensification, remaining at maximum for up to 15 minutes, then slowly decreasing—this pattern suggests coronary vasospasm 1.
• Pain triggered by exertion but occurring some time after activity and poorly responsive to nitrates suggests microvascular angina 1, 6.

High-Risk Features Requiring Immediate Emergency Evaluation

• Prolonged rest pain exceeding 20 minutes 1, 3.
• Accelerating tempo with increasing frequency, severity, or duration over 48 hours 1.
• New-onset severe angina (Canadian Cardiovascular Society Class III or IV) 1.
• Angina accompanied by syncope, presyncope, or hemodynamic instability 1.

Severity Classification (Canadian Cardiovascular Society)

• Class I: Ordinary activity does not cause angina; symptoms only with strenuous, rapid, or prolonged exertion 1, 2.
• Class II: Slight limitation of ordinary activity; angina with brisk walking, climbing more than one flight of stairs, or after meals 1, 2.
• Class III: Marked limitation; angina walking one to two blocks or climbing one flight of stairs at normal pace 1, 2.
• Class IV: Inability to perform any physical activity without discomfort; angina may occur at rest 1, 2.

Critical Pitfalls to Avoid

• Do not assume chest pain is non-cardiac if it is reproducible by palpation—while this makes coronary disease less likely, it does not exclude it, and careful evaluation is needed before dismissing cardiac causes 1, 2.

• Do not dismiss exertional dyspnea as purely pulmonary—in the context of extensive coronary disease, dyspnea may represent an anginal equivalent with significant prognostic implications 1, 2.

• Do not rely on nitroglycerin response as a diagnostic test—relief is not specific for myocardial ischemia and can occur with esophageal spasm or other non-cardiac causes 1.

• Do not overlook "stretch pain" in this patient with 19 stents—non-ischemic chest pain from continuous arterial wall stretching by stents is common (41% after stenting vs. 12% after angioplasty alone) and may persist intermittently for up to 10 weeks post-procedure 4, 5.

• Do not delay emergency evaluation when symptom patterns worsen—any increase in frequency, severity, duration, or occurrence at rest mandates immediate assessment for unstable angina or acute coronary syndrome 1, 3.

Ranolazine-Specific Considerations

• Ranolazine does not abort acute angina episodes—patients must understand that sublingual nitroglycerin remains the treatment for acute symptoms 7.

• Instruct the patient to report persistent symptoms despite ranolazine—the FDA label specifically directs patients to "tell your doctor if you still have symptoms of angina after starting Ranolazine" 7.

• This patient's recent dose escalation from 250 mg to 1000 mg twice daily is appropriate for refractory chronic stable angina, but ongoing symptoms require reassessment for unstable angina or non-ischemic causes 7, 8.